CLIC1 and glioblastoma: Additionally, CLIC1 expression in glioblastoma stem cells (GSCs) correlates with poor prognosis, and its inhibition via RNA silencing or antibody targeting reduces proliferation, clonogenicity, and tumorigenicity both in vitro and in vivo [48,49,50].